CalcMyPeptide
Anti-AgingAlso known as: Nicotinamide Adenine Dinucleotide, NAD

NAD+

NAD+ (Nicotinamide Adenine Dinucleotide) is an omnipresent, life-sustaining coenzyme found in every living cell, functioning as the foundational energetic currency of human biology. As we age past 30, catastrophic systemic declines in NAD+ lead directly to mitochondrial decay, neurodegeneration, and profound physical fatigue. Aggressive exogenous replenishment (usually via high-dose IV infusion or subcutaneous protocols) is the pinnacle of modern longevity medicine—forcing the instant restoration of cellular ATP, aggressively clearing brain fog, and chemically activating the body's innate anti-aging Sirtuin pathways.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Moderate3 peer-reviewed citations

Quick Stats

Half-LifeRapidly incorporated intracellularly; serum half-life <1 hour
Dose Range50-250 mg (SubQ) or 250-1000 mg (IV)
Frequency1-3× weekly
Vial Sizes100 mg, 500 mg
BioavailabilityIV (100%) or subcutaneous injection
Year Developed1906

Scientific Data

Molecular Formula
C21H27N7O14P2
Molecular Weight
663.43 g/mol
CAS Number
PubChem ID
Developer
Arthur Harden, Hans von Euler-Chelpin (Nobel 1929)

Mechanism of Action

NAD+ (Nicotinamide Adenine Dinucleotide) is a foundational coenzyme ubiquitous in every living cell, acting as the critical hydrogen and electron carrier in cellular respiration and redox reactions. Within the mitochondria, it cycles between its oxidized (NAD+) and reduced (NADH) states to facilitate the transfer of high-energy electrons through Complexes I and III of the electron transport chain, directly driving the oxidative phosphorylation that generates ATP.

Beyond basic energy metabolism, NAD+ operates as an essential, expendable substrate for critical longevity and regulatory enzymes. It is required for the activation of **sirtuins (SIRT1-7)**, a family of protein deacetylases that govern gene silencing, circadian rhythm, cellular stress resistance, and apoptosis. Furthermore, NAD+ is consumed by **PARPs (Poly ADP-Ribose Polymerases)** during DNA damage repair, and by **CD38** signaling proteins involved in calcium mobilization and immune response.

Because maintaining optimal NAD+ levels is metabolically expensive, concentrations naturally decline by up to 50% between the ages of 40 and 60. This systemic depletion severely impairs mitochondrial efficiency, diminishes DNA repair capacity, and downregulates sirtuin activity—all of which are fundamental drivers of biological aging and degenerative disease. While oral precursors (like NMN and NR) must navigate the salvage pathway to be converted step-wise into the active molecule, direct SubQ or IV administration of NAD+ immediately replenishes the intracellular pool, forcing rapid activation of these vital repair mechanisms.

Source: PMID: 29514064

Buffered vs. Unbuffered NAD+

When purchasing NAD+ for injection, you will often encounter "buffered" and "unbuffered" options. This distinction is entirely about injection comfort, not biological effectiveness. The biological molecule is identical.

Unbuffered NAD+ is the mainstream, standard form used by researchers. Because it is the pure, raw element, it has a naturally low, highly acidic pH in solution (around 3.0-4.0). When injected subcutaneously, this acidity causes a notorious sensory effect—often described as an intense stinging or burning at the injection site that can last a few minutes. However, it is the most affordable and widely available version.

Buffered NAD+ includes a pre-mixed alkalinizing agent (typically a mild sodium bicarbonate solution) in the reconstitution solvent. This raises the pH closer to neutral physiological levels (pH 7.4), significantly reducing or entirely eliminating the infamous "NAD burn". It is usually sold as a premium kit for individuals highly sensitive to injection site pain.

Background & History

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells, central to energy metabolism and DNA repair via sirtuins and PARP enzymes. While not a peptide, it is frequently categorized alongside injectable therapeutic compounds. Its role in aging was established by David Sinclair at Harvard (2013, Cell), demonstrating NAD+ decline drives mitochondrial dysfunction and that restoration reverses aging hallmarks in mice. NAD+ IV therapy and NMN precursors have become the most widely used longevity interventions in anti-aging medicine.

Research Use Cases

  • Mitochondrial energy production and biogenesis
  • Sirtuin activation for DNA repair and epigenetic maintenance
  • Addiction recovery support (shown to reduce withdrawal symptoms)
  • Neurodegenerative disease protection via PARP and SIRT1
  • Exercise performance and recovery via ATP production support

Dosing Protocol

Typical Dose50-250 mg (SubQ) or 250-1000 mg (IV)
Frequency1-3× weekly
Half-Life~45 minutes (IV)
Common Vial Sizes100 mg, 500 mg

Dosing Protocols

SubQ Protocol

Dose
50 - 100 mg
Frequency
Daily (SC) or 3-5x per week
Note: Subcutaneous is convenient for regular maintenance dosing. May cause injection site irritation at higher doses.

IV Infusion

Dose
250 - 1000 mg
Frequency
1-3x per week (slow IV infusion)
Note: Clinic-administered over 1-4 hours. Infuse slowly to avoid nausea and chest tightness. Higher bioavailability than SubQ.

Administration

Route
Subcutaneous injection or intravenous infusion
Timing
Morning preferred. No fasting required.
Fasting Required?
No — food timing not critical

Expected Timeline

Day 1-3 (IV)
Rapid energy boost, improved mental clarity. Nausea possible with first infusions — infuse slowly.
Week 2-4 (SubQ)
Improved mitochondrial energy production. Enhanced recovery from exercise.
Month 1-3
Sirtuin activation. DNA repair capacity improvement. Gradual anti-aging metabolic benefits.

Who Is It For?

Cellular Energy / Mitochondrial Health

High

Direct precursor to ATP production. Bypasses the conversion steps required by NMN/NR oral supplements.

Longevity / DNA Repair

Moderate

Activates sirtuins and PARP-mediated DNA repair. Declining NAD+ is a key mechanism of aging.

Reconstitution Example

Vial
100 mg
Water
2 mL
Concentration
50 mg/mL
Per Unit (100u syringe)
500 mcg
Dose of 50000 mcg = 100 units on a 100-unit insulin syringe

Safety & Considerations

Essential human coenzyme. IV administration may cause nausea and chest tightness if infused too rapidly — always infuse over 1-4 hours. SubQ may cause injection site discomfort. Well-established safety record.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Compounded Drug (Rx)

US Compounding: Available via licensed pharmacy Rx

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

IV NAD+ infusions can cause facial flushing, nausea, chest tightness at rapid infusion rates — always infuse slowly. PARP inhibitors (cancer drugs: olaparib, rucaparib) compete for NAD+ — do not combine with oncology treatment without oncologist input. Separate timing from alcohol (competes for NAD+ in metabolism).

Synergies & Common Stacks

NAD+ powers mitochondrial NADH cycling; MOTS-c signals AMPK to improve metabolic efficiency. Together they comprehensively support mitochondrial health.

Epitalon restores telomere length; NAD+ supports the DNA repair machinery (PARP) that requires NAD+ as substrate. Synergistic longevity combination.

NAD+ vs. Glutathione

AttributeNAD+Glutathione
Primary MechanismNAD+ restoration → mitochondrial fuelAntioxidant master regulator (GSH)
Cellular TargetSirtuins, PARP, mitochondrial ETCOxidative stress, glutathione peroxidase
Best ForEnergy, longevity, DNA repair, alcohol detoxSkin brightening, liver support, oxidative load
AdministrationIV, SC injection, oral (NMN/NR precursors)IV, SC injection, oral (liposomal)
Combined UseOften co-administered in IV drip protocolsOften co-administered in IV drip protocols

Verdict: NAD+ and Glutathione address complementary aspects of cellular health — NAD+ powers the cell, Glutathione protects it. They are frequently combined in IV wellness protocols for maximum synergy.

Dosing Quick Reference

NAD+— Dosing Guide
Dose Range
50-250 mg (SubQ) or 250-1000 mg (IV)
Half-Life
~45 minutes (IV)
Frequency
1-3× weekly
Route
Subcutaneous
100 mg vial500 mg vial
💧 2 mL BAC water📐 50 mg/mL concentration💉 500 mcg/unit (100u syringe)
Anti-Agingcalcmypeptide.com

Frequently Asked Questions

What is more effective — NAD+ IV or SubQ injection?
IV provides 100% bioavailability but requires clinic visits (1-4 hour infusions). SubQ is more convenient for regular home dosing. Both effectively raise intracellular NAD+ levels. IV is preferred for acute high-dose therapy; SubQ for maintenance.
Why do NAD+ levels decline with age?
NAD+ declines ~50% between ages 40-60 due to increased consumption by CD38, increased PARP activity from DNA damage accumulation, and decreased synthesis from the salvage pathway. This decline contributes to mitochondrial dysfunction and aging.

References

  1. Cantó C, Auwerx J "NAD+ metabolism and the control of energy homeostasis".” Cell Metabolism (2011). PMID: 21531334

📚 Related Articles

Recommended Source10% OFF

Get NAD+ from our recommended source — independently tested, COA-verified, USP <85> endotoxin compliant. Use code 4SS6SFTUGB at checkout.

Affiliate link · Full review